As a veterinary professional, you know that changes in your patients’ mobility can be early signs of canine osteoarthritis (OA), the leading cause of chronic pain in pets. Treat canine OA early so your patients can keep moving and doing the things they love.
Early detection of canine OA is a joint effort. Expand your canine OA toolbox by using our resources to assess and monitor your patients’ canine OA over time and to keep you in control of managing their OA pain and inflammation, while engaging pet owners.
Go with Galliprant® (grapipirant tablets) from first diagnosis. It’s a first-in-class non-COX inhibiting NSAID1 that can be used for all stages of OA, from earliest clinical signs**.
**Approved for use in dogs older than 9 months of age and greater than 8 pounds
Indication
Galliprant is an NSAID that controls pain and inflammation associated with osteoarthritis in dogs.
Important Safety Information
Not for use in humans. For use in dogs only. Keep this and all medications out of reach of children and pets. Store out of reach of dogs and other pets in a secured location in order to prevent accidental ingestion or overdose. Do not use in dogs that have a hypersensitivity to grapiprant. If Galliprant is used long term, appropriate monitoring is recommended. Concomitant use of Galliprant with other anti-inflammatory drugs, such as COX-inhibiting NSAIDs or corticosteroids, should be avoided. Concurrent use with other anti-inflammatory drugs or protein-bound drugs has not been studied. The safe use of Galliprant has not been evaluated in dogs younger than 9 months of age and less than 8 lbs (3.6 kg), dogs used for breeding, pregnant or lactating dogs, or dogs with cardiac disease. The most common adverse reactions were vomiting, diarrhea, decreased appetite, and lethargy. Click here for full prescribing information.
References
1 Kirkby Shaw K, Rausch-Derra LC, Rhodes L. Grapiprant: an EP4 prostaglandin receptor antagonist and novel therapy for pain and inflammation. Vet Med Sci. 2016;2:3-9.
PM-US-20-1626
©2020 Elanco or its affiliates. Elanco, Galliprant and the diagonal bar logo are trademarks of Elanco or its affiliates.
|